(Q38055062)

27 August 2017

title

"Antivirals" in the treatment of adult T cell leukaemia- lymphoma (ATLL). (English)

1 reference

27 August 2017

1 reference

Paul A Fields

1

1 reference

27 August 2017

Graham P Taylor

series ordinal

2

1 reference

27 August 2017

publication date

1 December 2012

1 reference

Current hematologic malignancy reports

27 August 2017

published in

1 reference

27 August 2017

volume

7

1 reference

27 August 2017

issue

4

1 reference

27 August 2017

page(s)

267-275

1 reference

Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

New therapeutic approaches for adult T-cell leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

New entity, definition and diagnostic criteria of cutaneous adult T-cell leukemia/lymphoma: human T-lymphotropic virus type 1 proviral DNA load can distinguish between cutaneous and smoldering types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Centrosome and retroviruses: the dangerous liaisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Human T cell lymphotropic virus type I Tax activates IL-15R alpha gene expression through an NF-kappa B site

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

21 January 2018

12 December 2020

HBZ and its roles in HTLV-1 oncogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Multi-step carcinogenesis model for adult T-cell leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

HTLV-1 bZIP factor impairs cell-mediated immunity by suppressing production of Th1 cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Natural history of adult T-cell leukemia/lymphoma and approaches to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Induction of an antiviral response by interferon requires thymidine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Human T-cell lymphotropic virus type I (HTLV-I)-associated adult T-cell leukemia-lymphoma in a patient infected with human immunodeficiency virus type 1 (HIV-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Interferon-α and zidovudine for relapsed/refractory adult T cell leukemia/lymphoma: case reports of Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Long-term study of indolent adult T-cell leukemia-lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Alpha interferon inhibits human T-cell leukemia virus type 1 assembly by preventing Gag interaction with rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Antiviral effect of zidovudine in the experimental model of adult T cell leukemia in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Susceptibility of primary HTLV-1 isolates from patients with HTLV-1-associated myelopathy to reverse transcriptase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Telomere attrition induces a DNA double-strand break damage signal that reactivates p53 transcription in HTLV-I leukemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Expression profiles of adult T-cell leukemia-lymphoma and associations with clinical responses to zidovudine and interferon alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Treatment of Adult T-Cell Leukemia-Lymphoma with Zidovudine and Interferon Alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

Meta-Analysis on the Use of Zidovudine and Interferon-Alfa in Adult T-Cell Leukemia/Lymphoma Showing Improved Survival in the Leukemic Subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0139-9

[Natural history of human T-lymphotropic virus type 1 (HTLV-1) infection].

21 January 2018

1 reference

12 December 2020

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: Human Immunodeficiency Viruses and Human T-Cell Lymphotropic Viruses. Lyon, France, 1-18 June 1996

1 reference

12 December 2020

IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma

1 reference

12 December 2020

Immunodeficiency in preclinical smoldering adult T-cell leukemia.

1 reference

12 December 2020

Pre-morbid human T-lymphotropic virus type I proviral load, rather than percentage of abnormal lymphocytes, is associated with an increased risk of aggressive adult T-cell leukemia/lymphoma

1 reference

12 December 2020

Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma

1 reference

12 December 2020

Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy

1 reference

12 December 2020

Impact of p53 aberration on the progression of Adult T-cell Leukemia/Lymphoma

1 reference

12 December 2020

Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study

1 reference

12 December 2020

10.1007/S11899-012-0139-9

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1028766543

0 references

1 reference